A28 Therapeutics
Pre-clinicalA28 Therapeutics develops novel small molecule therapies targeting RNA-modifying proteins for oncology and other diseases.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $92M
About
A28 Therapeutics develops novel small molecule therapies targeting RNA-modifying proteins for oncology and other diseases.
RNA & Gene Therapy
Funding History
4Total raised:$92M
Series A$25MJun 15, 2023
Series A$50MApr 15, 2023
Seed$12MJan 15, 2022
Seed$5MJun 15, 2021